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Phenylalanine Lowers Melanin Synthesis in Mammalian Melanocytes by 
Reducing Tyrosine Uptake: Implications for Pigment Reduction in 
Phenylketonuria 
RICHARD A. FARISHIAN AND J. R. WHITTAKER 
The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania, U.S.A. 
The effect of phenylalanine on melanogenesis was 
studied in the RPMI-3460 hamster melanoma cell line. L-
phenylalanine was a relatively weak competitive inhib-
itor of the tyrosinase activity in pigment cell homage-
nates but D-phenylalanine did not affect this tyrosinase 
activity. In vivo, 10 mM L- or D-phenylalanine inhibited 
the incorporation of labeled tyrosine into melanin. Since 
phenylalanine reduced the size of the acid-soluble intra-
cellular tyrosine pool relative to controls, this reduction 
is proposed as the cause of the diminished incorporation 
of tyrosine into melanin. In addition, melanin synthesis 
generated from endogenous tyrosine, in the absence of 
tyrosine in the culture medium, was not affected by the 
presence of L- or D-phenylalanine. Phenylalanine-re-
lated depression of melanin synthesis in cell culture 
therefore, was not caused by inhibition of tyrosinase 
activity, but by restriction of tyrosine uptake by phen-
ylalanine. The results with this mammalian cell model 
suggest that the pathologic phenylalanine:tyrosine im-
balance found in phenylketonuria (PKU) may cause a 
reduction of melanin synthesis in hair follicles and nor-
mally pigmented areas of the brain by affecting uptake 
of tyrosine by melanocytes. The reduced pigmentation 
in PKU is more likely to be caused by reduced serum 
tyrosine levels and by competition for tyrosine uptake 
with phenylalanine than by phenylalanine inhibition of 
tyrosinase activity. 
L-phenylalanine has been implicated as an inhibitor of mel-
anin pigment synthesis in individuals having the amino acid 
disorder phenylketonuria (PKU) [1-3]. PKU patients charac-
teristically exhibit a variety of neurologic and pigmentary ab-
normalities; pertinent to the present investigation are the light-
ening of hair color and the decreased pigmentation of the 
substantia nigra and locus ceruleus [3]. Current research indi-
cates that PKU is due to a genetically related deficiency of 
phenylalanine hydroxylase [ 4-6] or dihydropteridine reductase 
[7], in which the conversion of phenylalanine to tyrosine is 
severely impaired. The manifestations of PKU are caused by 
t he high phenylalanine and low tyrosine concentrations in the 
sera and cerebrospinal fluid of these individuals [3, 8-11]. 
Phenylalanine inhibits mammalian tyrosinase (E.C. 1.14.3.1) 
activity [1,2] and depresses the uptake of tyrosine in cell and 
Manuscript received April 26, 1979; accepted for publication August 
19, 1979. 
This work was supported by USPHS grants CA 17591 and CA 23394 
from the National Cancer Institute, and by an institutional appropria-
tion from the State of Pennsylvania. 
Dr. Farishian's present address is Bethesda Research Labs, Inc., 411 
N. Stonestreet Avenue, Rockville, MD 20850. 
Reprint requests to: Dr. J . R. Whittaker, The Wistar Institute of 
Anatomy and Biology, 36th Street at Spruce, Philadelphia, Pennsyl-
vania 19104. 
Abbreviations: 
MEM: Eagle's minimal medium 
PKU: phenylketonuria 
T CA: trichloroacetic acid 
85 
tissue culture [12-16]. Tyrosinase catalyzes the oxidation of 
tyrosine to dihydroxyphenylalanine (DOPA) and DOPA to 
dopaquinone which is, in turn, autooxidized to form melanin 
[17-19]. Unlike tyrosine hydroxylase (E.C. 1.14.16.2) [20], ty-
rosinase cannot hydroxylate phenylalanine [21]. In most in-
stances, pigment cells are tyrosine auxotrophs (but see Ref. 22) 
and do not use phenylalanine for melanin synthesis [21]. What-
ever its effect on tyrosinase activity and melanogenesis, phen-
ylalanine is actually utilized only for protein synthesis. 
The present investigation demonstrates that phenylalanine 
inhibition of melanogenesis was not due to its effect on tyrosin-
ase activity, but to the competitive inhibition of tyrosine uptake 
by phenylalanine. The high serum phenylalanine and low serum 
tyrosine concentrations present in phenylketonurics may be 
responsible for the pigmentary alterations observed in PKU. 
MATERIALS AND METHODS 
Cell Culture 
RPMI-3460 hamster melanoma cells [23] obtained from Dr. R. L. 
Davidson have been propagated in our laboratory for the past 6 yr. A 
highly melanotic subline, CS1, was used in the experiments described 
here. This subline is not anchorage-dependent and has a generation 
time of about 13 hr. Stock cultures were maintained in Eagle 's Minimal 
Essential Medium (MEM, Flow Labs.) with 2x vitamins, and supple-
mented with 10% fetal bovine serum (Irvine Scientific Sales Co., Inc. , 
Santa Ana, Calif.). This medium, with dialyzed serum, was also used 
when pulse-labeling cells. 
Cultures were monitored on a weekly basis for mycoplasma contam· 
ination by the uridine phosphorylase assay [24]. Only uninfected cul-
tures were maintained or used for experiments. 
Cultures were prepared for experiments by methods previously de-
scribed [25]. 
Uptake and Incorporation of Radioactive Compounds 
D,L-[2- 14C]tyrosine and 2-[2- 14C]thiouracil (Amersham-Searle) were 
used to measure melanin synthesis [21,25,26]. Validation of these meth-
ods is detailed elsewhere [25]. Briefly, D,L-[2-14C]tyrosine incorpora-
tion, in the presence of cycloheximide (50 ,ug/ rnl) , into hot trichloroace-
tic acid (TCA) insoluble material represents incorporation into melartin 
[21,25]. Only the L-tyrosine isomer is incorporated [25], but the L- and 
D-tyrosine isomers are transported equally and each accounts for 50% 
of the total TCA-soluble (free intracellular) D,L-[2-"C]tyrosine radio-
activity [25]. Thus, measw-ement of the utilizable intracellular L-[2-
14C]tyrosine pool is determined by dividing the total TCA-soluble D,L-
[2-14C]tyrosine radioactivity by 2 [25]. The D,L-[2-14C]tyrosine uptake 
figures presented in this communication reflect this operation. We 
found it necessary to use D,L-[2- 14C]tyrosine because the repeated 
enzymatic and non-enzymatic oxidation of tyrosine that results in the 
formation of melanin [27] precludes the use of L-[l-14C]tyrosine, L-[U-
14C]tyrosine, or any of the commercially available [3H]tyrosines. 14C-
Tyrosine labeled in the 2-carbon position is only available as a racemic 
mixture. · 
Exogenous thiouracil becomes part of the melanin polymer by bind· 
ing to the quinones generated during the synthesis of melanin [26,27]. 
Since quinones are rarely found in other eucaryotic cells, the incorpo-
ration of 2-[2- 14C]thiouracil is specific for newly synthesized melanin 
pigment [26]. As with radioactive tyrosine, 2-[2- 14C]thiouracil incorpo· 
ration is completely TCA-insoluble and is dependent upon tyrosinase 
activity. The rates of radioactive tyrosine and thiouracil incorporations 
into melanin are optimal at an external L-tyrosine concentration of 0.6 
mM and, when 2-[2- 14C]thiouracil is used, at l mM 2-thiouracil [25]. In 
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addition, the incorporations into melanin of both radioactive com-
pounds are linear [25]. No tyrosinase-related cofactors are ever em-
ployed in our cellular metabolic experiments over time. 
Tyrosine and thiouracil uptake reach steady-state distribution within 
30 and 5-10 min of incubation, respectively [25]. Thiouracil uptake and 
the intracellular thiouracil pool size are affected only by the external 
thiouracil concentration [25]. 
Assay of TCA Fractions 
RPMI-3460 CS1 cells pulsed with either D,L-[2-"C]tyrosine or 2-[2-
14C]thiouracil were precipitated twice with 5% cold TCA. Samples from 
the pooled TCA-soluble fraction were added to Aquasol scintillation 
fluid (New England Nuclear) and counted. The TCA-insoluble residues 
of cells pulsed with radioactive tyrosine were subjected to a third 
(90°C) TCA precipitation [28]. All TCA-insoluble residues were lipid-
extracted [21]. The dried residues were solubilized in 1 N NaOH by 
heating for 10 min in a boiling water bath. Samples of the NaOH digests 
were assayed for protein content [29]. The melanin in these digests did 
not interfere significantly with the Lowry protein determination [30]. 
For scintillation counting, 0.1 rnl volumes were added to 18 ml of 30% 
methanol in toluene containing 0.4% PPO and 0.005% POPOP. In all 14C scintillation counting, when the raw cpm were not significantly 
higher than background, i.e. < 100 cpm vs. 50 cpm background, a 
minimum of 1500 counts were recorded. Usually, however, the samples 
contained more than 150 cpm, and were counted for 10 min. The 
counting efficiency for 14C was > 87%. 
Tyrosinase Assay 
Tyrosinase activity was measured according to the procedure de-
scribed by Pomerantz [18]. Briefly, RPMI-3460 CS1 cells were homog-
enized in 0.5% sodium deoxycholate; portions of the homogenate were 
added to an incubation mixture consisting of (final concentrations) 0.8 
mM L-tyrosine, 0.12 mM L-DOPA, 0.012 mM neutralized ascorbate, 20 
mM sodium phosphate buffer (pH 6.8 at 37°C), and 3 ,uCi/rnl of L-[3,5-
3H]tyrosine (Amersham-Searle; final specific activity, 1.5 mCi/mmole). 
When present, the concentration of phenylalanine was 1-30 mM. Boiled 
homogenate (100°C for 10 min) was used for controls [18]. The back-
ground radioactivity produced in these controls was similar to that 
obtained by" incubation with 1 mM diethyldithiocarbamate. Both meth-
ods completely abolish tyrosinase activity as evidenced by the lack of 
an increase in background activity over time. The enzyme reaction was 
run at 37°C for 1 hr, and was terminated by the addition of meta-
phosphoric acid. The precipitated homogenates were passed through 
columns of Norit A/Celite 535 (Johns-Manville) to remove organically 
bound label. The columns were washed extensively with distilled/ 
deionized water and samples of the eluate added to Aquasol scintillation 
fluid. The eluate contains [3H]OH which results from the oxidation of 
L-[3,5-3H]tyrosine at the 3 position; the production of tritiated water is 
thus the measure ·of tyrosinase activity, expressed as ,umoles tyrosine 
converted (to DOPA)/mg protein/hr. In 3H scintillation counting back-
grounds were typically 50-55 cpm. The raw cpm of the data presented 
in the figures were always at least 3 times the background cpm. A 
minimum of 2000 counts were recorded for all samples. The counting 
efficiency for 3H was > 38%. 
Chemicals 
Chemicals were purchased from the Sigma Chemical Corp., St. Louis. 
RESULTS 
Inhibition of Mammalian Tyrosinase Activity by £-
Phenylalanine 
The effect of phenylalanine on the tyrosine-tyrosinase reac-
tion is shown in Fig. 1. The relationship between L-phenylala-
nine concentration in the homogenate and the inhibition of 
tyrosinase activity is essentially linear (Fig 1a). The inhibition 
was clearly stereospecific for L-phenylalanine; D-phenylalanine 
had no effect (Fig 1a). Figure 1b shows that tyrosine competes 
with the phenylalanine inhibition of tyrosinase and suggests 
that L-phenylalanine binds to the active site. The competitive 
nature of the L-phenylalanine inhibition was confirmed by 
Lineweaver-Burk analysis (Fig 2). L-phenylalanine (10 mM) 
caused a 3-fold increase in Km, and was a relatively weak 
competitive inhibitor (Ki = 5 X 10- 3 M). The Km of 2.6 X 10- 4 
M for hamster tyrosinase approximates that observed by other 
investigators [18,31,32). 
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FIG 1. Effect of L- and D-phenylalanine on hamster tyrosinase 
activity. RPMI-3460 CS1 hamster melanoma cells were homogenized 
and assayed for tyrosinase activity as described in the Materials and 
Methods. A, tyrosinase activity in the presence of phenylalanine (L = 
o; D = x). The ability of L-tyrosine to compete with the inhibition of 
tyrosinase activity by phenylalanine (10 mM) is shown in panel B. One 
hundred percent of activity = 0.426 ,umoles tyrosine converted/ mg 
protein/hr. Similar results were obtained in 4 other experiments. 
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FIG 2. Kinetics of hamster melanoma tyrosinase activity in the 
presence of 10 mM L-phenylalanine. RPMI-3460 CS! hamster mela-
noma cells were homogenized and assayed for tyrosinase activity. Km 
and Km "~'~'were obtain·ed by linear regression analysis. [S] = L-tyrosine. 
A, minus phenylalanine, Km = 2.6 X w-• M; B, plus 10 mM phenylala-
nine K, HPP = 7.6 X w-• M. Representative data from 3 experiments. 
Inhibition of D,L-{2- 14 C}tyrosine Uptake by L-and D-
phenylalanine 
In RPMI-3460 melanoma cell cultures, the uptake of tyrosine, 
and its incorporation into melanin were not affected by the 
Feb. 1980 EFFECT OF PHENYLALANINE ON MELANIN SYNTHESIS 87 
TABLE I. D,L-[2- 14C]tyrosine uptake and incorporation (into melanin), in the presence of normal and PKU levels of tyrosine and 
phenylalanine, by RPMI-3460 CSJ hamster melanoma cells 
Normal 
PKU 
Normal 
PKU 
[L·phenylalanine] 
0.10 mM 
1.50 mM 
0.10 mM 
1.50 mM 
Normal 
PKU 
[L-tyrosine] TCA-soluble fraction• TCA-insoluble fraction• 
0.10 mM 8,900 9,900 
0.10 mM 8,400 10,100 
0.01 mM 990 1,000 
0.01 mM 900 1,050 
" dpm L-[2-' ''C]tyrosine/ mg protein. 
Cells were pulsed for 4 hr with D,L-[2-'''C]tyrosine (specific activity normalized to 1 mCi/mmole) in MEM containing concentrations of L-
phenylalanine and L-tyrosine approximating those found in the sera of PKU and non-PKU (normal) patients [33-36]. The pulse medium also 
contained cycloheximide (50 !Lg/ ml) to inhibit tyrosine incorporation into protein. Figures are mean values of 5 cultures, and are the averaged 
data of 3 experiments. 
presence of serum PKU levels of phenylalanine. In this exper-
iment, cells were incubated in MEM containing radioactive 
tyrosine and approximately "normal" vs. PKU serum levels of 
phenylalanine and tyrosine [3,33-36]. The results with L-phen-
ylalanine are shown in Table I; similar results were obtained 
with the D isomer. Neither normal (0.1 mM) nor PKU (1.5 mM) 
phenylalanine concentrations were effective in changing tyro-
sine uptake and incorporation into melanin. The only difference 
observed was the tyrosine uptake and incorporation into mel-
anin at 0.1 and 0.01 mM L-tyrosine. Both incorporation and 
uptake are known to be concentration-dependent [25]. 
We subsequently found that it was possible to inhibit melanin 
synthesis by using a much higher phenylalanine concentration. 
As shown in Fig. 3, both 10 mM D- and L-phenylalanine 
markedly inhibited tyrosine uptake by RPMI-3460 CS1 mela-
noma cells. In addition, the time-comse for the establishment 
of steady-state tyrosine distribution was similar to the control 
(Fig 3, curve A). This is not smprising, since phenylalanine and 
tyrosine are probably transported across the plasma membrane 
by the same carrier mechanism [37-39]. The similar satmatidn 
kinetics of tyrosine uptake in the presence or absence of phen-
ylalanine indicate that differences in tyrosine incorporation 
may be correlated with differences in the intracellular tyrosine 
pool size. This does not mean that melanin is synthesized from 
the intracellular tyrosine pool, but that, in the presence of 
phenylalanine, tyrosine incorporation may be limited by its 
competition for uptake by phenylalanine. Also note from Fig 3 
that the inhibition of tyrosine uptake by phenylalanine was not 
stereospecific for L-phenylalanine. Cmves for 0 mM and 1 mM 
phenylalanine were virtually identical to cmve A. 
D,L-[2- 14C}tyrosine Incorporation into Melanin in the 
Presence of L- and D-phenylalanine 
In the presence of cycloheximide (50 J.Lg/ml), the D ,L-[2- 14C] 
tyrosine measmed in the hot TCA-insoluble fraction of RPMI-
3460 CS1 cells represents incorporation into melanin [21,25]. 
We have shown that cycloheximide stimulates melanin synthe-
sis by about 30% [21,25]. Thus, tyrosine incorporation into 
melanin is 130% of that of control cultures incubated without 
cycloheximide. With this in mind, RPMI-3460 CS1 melanocytes 
were pulsed with radioactive tyrosine in the presence or absence 
of cycloheximide and phenylalanine (Table II). First, note that 
cycloheximide did not affect the size of the intracellular tyrosine 
pool (TCA-soluble fraction). When the TCA-insoluble figures 
were corrected for cycloheximide stimulation, i.e., divided by 
1.3, the tyrosine incorporation into melanin can be seen to have 
been inhibited by both L- and D-phenylalanine. It is inferred 
from Fig 3 that phenylalanine not only reduced the steady-state 
size of the intracellular tyrosine pool, but also proportionately 
depressed the kinetics of tyrosine uptake. We previously showed 
that incorporation of tyrosine into melanin was directly related 
to its uptake [25]. In Table II, the relative ratios of TCA-
insoluble (corrected)/TCA-soluble show that the phenylalanine 
values are not significantly different from control values. Thus, 
the inhibition of melanin synthesis may be caused by decreased 
tyrosine uptake. 
30>,-------------------------------
w 
:::.:::_ 
~~ 
o...O 
:::)-
)( 
w-
zz 
en-ow 
0::1-
>-0 t--8: 
20 
.----. Ol 
.,.
0 E 10 
' I E ~a. 
,-o 
_j 
6 
5 10 
• 
.A 
------
_ ___.....___-----------"'· c 
--------8 
• 
20 30 60 
PULSE TIME (Min) 
FIG 3. Uptake of D,L-[2-"C]tyrosine by RPMI-3460 CSI hamster 
melanoma cells in the presence or absence of phenylalanine. Cells were 
pulsed with D,L-[2-14C]tyrosine (0.6 mM; specific activity 1 mCi/ 
mmole) , collected at the times indicated, and assayed for TCA soluble 
radioactivity. Figure shows uptake of the L-[2-"C) tyrosine isomer only. 
A, 0.1 mM L-phenylalanine; B, 10 mM L-phenylalanine; C, 10 mM D-
phenylalanine. Each point is the mean value for 5 cultures, and repre-
sents data from 3 experiments. 
Effect of Phenylalanine on Melanin Synthesis, as Measured 
by 2-{2-14C] Thiouracil, in the Presence or Absence of 
Exogenous Tyrosine 
RPMI-3460 CS1 melanocytes are able to synthesize consid-
erable amounts of melanin for at least 4 hr in the absence of 
externally supplied tyrosine [25,40). Under these conditions, 
endogenous tyrosine is converted to melanin and this can be 
measured by 2-[2- 14C]thiouracil incorporation [21,25,26]. We 
used this featUl'e of melanin synthesis to separate the tyrosine/ 
phenylalanine uptake component from the experimental sys-
tem. Accordingly, cells were preincubated in MEM containing 
0.6 mM L-tyrosine, then pulsed with radioactive thiouracil in 
the presence or absence of tyrosine and phenylalanine (Table 
III) . It is clear 'that when the cells were required to utilize only 
endogenous tyrosine for melanin synthesis, phenylalanine had 
absolutely no effect on this process. Phenylalanine does not 
interfere with tyrosinase activity in vivo; melanogenesis is de-
pressed because phenylalanine limits tyrosine transport across 
the plasma membrane. 
DISCUSSION 
We have used the RPMI-3460 hamster melanoma cell line as 
a model to show that high levels of phenylalanine depress 
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TABLE II. Effect of 10 mM .L· or D-phenylalanine on the uptahe and incorporation of D,L-[2- 14C]tyrosine in RPMI-3460 CSJ hamster 
melanoma cells 
Condition 
0 Phe 
0 Phe, CXM 
10 mM L-Phe 
10 mM L-Phe, CXM 
10 mM D-Phe 
10 mM D-Phe, CXM 
TCA-soluble 
fraction" 
25,300 
25,100 
12,900 
10,900 
15,900 
14,400 
" dpm L-[2- 14C]tyrosine/ mg protein. 
% inhibition of 
uptake by Phe 
57 
43 
TCA-
insoluble 
fraction" 
108,100 
81,900 
59,800 
35,900 
76,600 
48,200 
CXM -corrected TCA-insoluble %change by TCA-insoluble % inhibition by Phe corrected 
fraction"· • TCA-soluble Phe 
63,000 2.51 
27,600 56 2.54 1j 
37,100 41 2.58 3j 
"The CXM-corrected TCA-insoluble figures are the TCA-insoluble figures divided by 1.3 (see text). 
Cells were pulsed for 4 hr with D,L-[2YC]tyrosine (0.6 mM L-tyrosine; specific activity, 1 mCi/mmole) under the conditions noted in the Table. 
CXM, cycloheximide; Phe, phenylalanine. Figures are mean values of 5 cultures, and are the averaged data of 3 experiments. 
TABLE III. Effect of phenylalanine on the incorporation of 
2-[2-14C]thiouracil into melanin, in the presence or absence of 
exogenous tyrosine, by RPMI-3460 CSI hamster melanoma cells 
Condition 
0 L-tryosine, 0 Phe 
0 L-tyrosine, 10 mM L-Phe 
0 L-tyrosine, 10 mM D-Phe 
0.6 mM L-tyrosine, 0 Phe 
0.6 mM L-tyrosine, 10 mM L-Phe 
0.6 mM L-tyrosine, 10 mM D-Phe 
Melanin syn- % inhibition of 
thesis dpm/ incorporation by 
mg protein Phe 
14,600 
14,600 
14,500 
45,300 
28,100 
32,100 
0 
0 
38 
29 
Cells were pulsed for 4 hr with 2-[2- 1'C]thiouracil (1 mM; specific 
activity, 1 mCi/mmole) under the conditions described in the Table. 
Phe, phenylalanine. Figures are mean values of 5 cultures, and are the 
averaged data of 3 experiments. 
melanin synthesis by limiting uptake of tyrosine and not by 
inhibiting tyrosinase activity [1,2]. In other cell culture systems, 
phenylalanine is transported predominantly by the sodium-
independent L system, while tyrosine is suggested to be trans-
ported equally by both the L and A (sodium-dependent) sys-
tems [38, p 178]. The ratio of phenylalanine to tyrosine in most 
of the experiments presented here was 100:1 (10 mM:0.1 mM), 
so it is conceivable that tyrosine uptake via the L system was 
almost completely blocked by eith er D- or L-phenylalanine. 
This .would account for the observation that phenylalanine 
inhibited tyrosine uptake by about 50% (Fig 3; Tables II and 
III) . We are currently investigating the amino acid transport 
properties of our melanoma cell line. 
With the exception that normally pigmented regions of the 
brain (substantia nigra, locus ceruleus [3]) are less pigmented 
in PKU [3], the pigmentary deficiencies of phenylketonurics 
are clinically less significant than are the neurologic abnormal-
ities. Nevertheless, abnormally high tissue phenylalanine con-
centrations may restrict the uptake of tyrosine in the nervous 
system as well [13,14]. Melanin, catecholamine, and general 
protein synthesis may all be impaired because of a severe 
tyrosine deficiency (rate-limiting for synthesis). Also, high con-
centrations of phenylalanine are known to adversely affect 
other cellular processes, including inhibition by phenylalanine 
of tyrosine metabolism in the rat liver [ 40]; inhibition of ribo-
somal protein synthesis in rabbit brain [10]; depletion of 
branched-chain amino acids in rat brain [9]; phenylalanine-
induced polyribosome disaggregation in mouse brain [ 41]; a 
decrease in fetal amino acid uptake, and brain pyruvate kinase, 
in experimentally induced maternal PKU [ 42]; saturation of 
blood brain barrier (BBB) transport of amino acids by phen-
ylalanine, thus restricting the transport across the BBB of other 
large neutral amino acids [ 43]. There are, therefore, many sites 
at which phenylalanine can disrupt or impede cell metabolism. 
In our experimental system, PKU levels of phenylalanine had 
no effect on melanin synthesis. Since external tyrosine concen-
tration was rate limiting for melanin synthesis [Table I; see also 
Refs 25,26], low serum tyrosine concentrations may be the 
primary cause of the neurologic and pigmentary deficiencies 
manifested in PKU. 
The technical assistance of Mr. Earle Flick is gratefully 
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